PTLD

Clinical trials for PTLD explained in plain language.

Never miss a new study

Get alerted when new PTLD trials appear

Sign up with your email to follow new studies for PTLD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

Could a cancer drug stop a deadly complication in transplant patients?

Prevention Not yet recruiting

This study tests whether the drug rituximab can safely clear Epstein-Barr virus (EBV) from the blood of people who have received a solid organ transplant. High levels of EBV can lead to a serious cancer called post-transplant lymphoproliferative disorder (PTLD). The trial will en…

Matched conditions: PTLD

Phase: PHASE1 • Sponsor: Jennifer Amengual • Aim: Prevention

Last updated Jun 27, 2026 13:00 UTC

PTLD

Get alerted when new PTLD trials appear

Could a cancer drug stop a deadly complication in transplant patients?